Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1983 2
1984 1
1985 4
1986 2
1987 5
1988 1
1989 2
1990 1
1991 8
1992 4
1993 3
1994 7
1995 1
1996 8
1997 3
1998 6
1999 5
2000 8
2001 3
2002 9
2003 2
2004 4
2005 8
2006 7
2007 3
2008 9
2009 9
2010 8
2011 11
2012 12
2013 11
2014 12
2015 10
2016 10
2017 18
2018 17
2019 22
2020 31
Text availability
Article attribute
Article type
Publication date

Search Results

265 results
Results by year
Filters applied: . Clear all
Page 1
CRISPR-Cas12-based detection of SARS-CoV-2.
Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, Miao X, Streithorst JA, Granados A, Sotomayor-Gonzalez A, Zorn K, Gopez A, Hsu E, Gu W, Miller S, Pan CY, Guevara H, Wadford DA, Chen JS, Chiu CY. Broughton JP, et al. Among authors: hsu e. Nat Biotechnol. 2020 Jul;38(7):870-874. doi: 10.1038/s41587-020-0513-4. Epub 2020 Apr 16. Nat Biotechnol. 2020. PMID: 32300245
Postoperative interventions to reduce inflammatory complications after third molar surgery: review of the current evidence.
Cho H, Lynham AJ, Hsu E. Cho H, et al. Among authors: hsu e. Aust Dent J. 2017 Dec;62(4):412-419. doi: 10.1111/adj.12526. Epub 2017 Jun 14. Aust Dent J. 2017. PMID: 28498604 Free article. Review.
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Moreno C, Greil R, Demirkan F, Tedeschi A, Anz B, Larratt L, Simkovic M, Samoilova O, Novak J, Ben-Yehuda D, Strugov V, Gill D, Gribben JG, Hsu E, Lih CJ, Zhou C, Clow F, James DF, Styles L, Flinn IW. Moreno C, et al. Among authors: hsu e. Lancet Oncol. 2019 Jan;20(1):43-56. doi: 10.1016/S1470-2045(18)30788-5. Epub 2018 Dec 3. Lancet Oncol. 2019. PMID: 30522969 Clinical Trial.
From Osteoimmunology to Osteomicrobiology: How the Microbiota and the Immune System Regulate Bone.
Hsu E, Pacifici R. Hsu E, et al. Calcif Tissue Int. 2018 May;102(5):512-521. doi: 10.1007/s00223-017-0321-0. Epub 2017 Oct 10. Calcif Tissue Int. 2018. PMID: 29018933 Free PMC article. Review.
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, de Lima Lopes G Jr, Grivas P, Painter CA, Peters S, Thompson MA, Bakouny Z, Batist G, Bekaii-Saab T, Bilen MA, Bouganim N, Larroya MB, Castellano D, Del Prete SA, Doroshow DB, Egan PC, Elkrief A, Farmakiotis D, Flora D, Galsky MD, Glover MJ, Griffiths EA, Gulati AP, Gupta S, Hafez N, Halfdanarson TR, Hawley JE, Hsu E, Kasi A, Khaki AR, Lemmon CA, Lewis C, Logan B, Masters T, McKay RR, Mesa RA, Morgans AK, Mulcahy MF, Panagiotou OA, Peddi P, Pennell NA, Reynolds K, Rosen LR, Rosovsky R, Salazar M, Schmidt A, Shah SA, Shaya JA, Steinharter J, Stockerl-Goldstein KE, Subbiah S, Vinh DC, Wehbe FH, Weissmann LB, Wu JT, Wulff-Burchfield E, Xie Z, Yeh A, Yu PP, Zhou AY, Zubiri L, Mishra S, Lyman GH, Rini BI, Warner JL; COVID-19 and Cancer Consortium. Kuderer NM, et al. Among authors: hsu e. Lancet. 2020 Jun 20;395(10241):1907-1918. doi: 10.1016/S0140-6736(20)31187-9. Epub 2020 May 28. Lancet. 2020. PMID: 32473681 Free PMC article.
Preface.
Hsu E. Hsu E. Results Probl Cell Differ. 2015;57:v-vi. doi: 10.1017/s2042170200002035. Results Probl Cell Differ. 2015. PMID: 26710368 No abstract available.
The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression.
Tyagi AM, Yu M, Darby TM, Vaccaro C, Li JY, Owens JA, Hsu E, Adams J, Weitzmann MN, Jones RM, Pacifici R. Tyagi AM, et al. Among authors: hsu e. Immunity. 2018 Dec 18;49(6):1116-1131.e7. doi: 10.1016/j.immuni.2018.10.013. Epub 2018 Nov 13. Immunity. 2018. PMID: 30446387 Free PMC article.
Paget's disease of bone: updates for clinicians.
Hsu E. Hsu E. Curr Opin Endocrinol Diabetes Obes. 2019 Dec;26(6):329-334. doi: 10.1097/MED.0000000000000503. Curr Opin Endocrinol Diabetes Obes. 2019. PMID: 31574000 Review.
Beta 2 Agonists.
Hsu E, Bajaj T. Hsu E, et al. 2020 Jun 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. StatPearls. 2020 Jan–. PMID: 31194406 Free Books & Documents. Review.
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Barrientos JC, O'Brien S, Brown JR, Kay NE, Reddy NM, Coutre S, Tam C, Mulligan S, Jaeger U, Devereux S, Pocock C, Robak T, Schuster SJ, Schuh A, Gill D, Bloor A, Dearden C, Moreno C, Cull G, Hamblin M, Jones JA, Eckert K, Solman IG, Suzuki S, Hsu E, James DF, Byrd JC, Hillmen P. Barrientos JC, et al. Among authors: hsu e. Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):803-813.e7. doi: 10.1016/j.clml.2018.08.007. Epub 2018 Aug 18. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30249389 Free PMC article. Clinical Trial.
265 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback